SAHA Capture Compound - A novel tool for the profiling of histone deacetylases and the identification of additional vorinostat binders

Proteomics

Volumn 11, Issue 20, 2011, Pages 4096-4104

  Fischer, Jenny J ^a   Michaelis, Simon ^a   Schrey, Anna K ^a   Diehl, Anne ^b   Graebner, Olivia Y ^a   Ungewiss, Jan ^a   Horzowski, Sabine ^a   Glinski, Mirko ^a   Kroll, Friedrich ^a   Dreger, Mathias ^a   Koester, Hubert ^a  

^a Caprotec Bioanalytics GmbH   (Germany)

^b LEIBNIZ INSTITUT FÜR MOLEKULARE PHARMAKOLOGIE   (Germany)

Author keywords

Biomedicine; Capture Compound Mass Spectrometry; Chemical proteomics; Histone deacetylase; Isochorismatase domain containing protein 2; Suberoylanilide hydroxamic acid

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 2A; HISTONE DEACETYLASE 1; HISTONE DEACETYLASE 2; HISTONE DEACETYLASE 3; HISTONE DEACETYLASE 6; HYDROLASE; ISOCHORISMATASE DOMAIN CONTAINING PROTEIN 2; UNCLASSIFIED DRUG; VORINOSTAT;

AMINO ACID SEQUENCE; ARTICLE; CELL LYSATE; CHEMICAL STRUCTURE; HUMAN; HUMAN CELL; LIVER CELL; LIVER METABOLISM; MASS SPECTROMETRY; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN CROSS LINKING; PROTEOMICS;

CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG DELIVERY SYSTEMS; DRUG DESIGN; HISTONE DEACETYLASE INHIBITORS; HISTONE DEACETYLASES; HUMANS; HYDROXAMIC ACIDS; MODELS, MOLECULAR; MOLECULAR STRUCTURE; PROTEOMICS;

EID: 80053968084     PISSN: 16159853     EISSN: 16159861     Source Type: Journal    
DOI: 10.1002/pmic.201000717     Document Type: Article

References (23)

1. Grant, S., Easley, C., Kirkpatrick, P., Vorinostat. Nat. Rev. Drug Discov. 2007, 6, 21-22.
2. Richon, V. M., Emiliani, S., Verdin, E., Webb, Y. et al., A class of hybrid polar inducers of transformed cell differentiation inhibits histone deacetylases. Proc. Natl. Acad. Sci. USA 1998, 95, 3003-3007.
3. LaBonte, M. J., Wilson, P. M., Fazzone, W., Groshen, S. et al., DNA microarray profiling of genes differentially regulated by the histone deacetylase inhibitors vorinostat and LBH589 in colon cancer cell lines. BMC Med. Genomics 2009, 2, 67.
4. Choudhary, C., Kumar, C., Gnad, F., Nielsen, M. L. et al., Lysine acetylation targets protein complexes and co-regulates major cellular functions. Science 2009, 325, 834-840.
5. Kelly, W. K., Marks, P. A., Drug insight: histone deacetylase inhibitors - development of the new targeted anticancer agent suberoylanilide hydroxamic acid. Nat. Clin. Pract. Oncol. 2005, 2, 150-157.
6. Blais, D. R., Brulotte, M., Qian, Y., Belanger, S. et al., Activity-based proteome profiling of hepatoma cells during hepatitis C virus replication using protease substrate probes. J. Proteome Res. 2010, 9, 912-923.
7. Huang, X., Shi, Z., Wang, W., Bai, J. et al., Identification and characterization of a novel protein ISOC2 that interacts with p16INK4a. Biochem. Biophys. Res. Commun. 2007, 361, 287-293.
8. Fischer, J. J., Graebner Baessler, O. Y., Dalhoff, C., Michaelis, S. et al., Comprehensive identification of staurosporine-binding kinases in the hepatocyte cell line HepG2 using Capture Compound Mass Spectrometry (CCMS). J. Proteome Res. 2010, 9, 806-817.
9. Nielsen, T. K., Hildmann, C., Dickmanns, A., Schwienhorst, A., Ficner, R., Crystal structure of a bacterial class 2 histone deacetylase homologue. J. Mol. Biol. 2005, 354, 107-120.
10. Luo, Y., Fischer, J. J., Baessler, O. Y., Schrey, A. K. et al., GDP-capture compound - a novel tool for the profiling of GTPases in pro- and eukaryotes by capture compound mass spectrometry (CCMS). J. Proteomics 2010, 73, 815-819.
11. Barsnes, H., Vizcaino, J. A., Eidhammer, I., Martens, L., PRIDE converter: making proteomics data-sharing easy. Nat. Biotechnol. 2009, 27, 598-599.
12. Olzmann, J. A., Li, L., Chudaev, M. V., Chen, J. et al., Parkin-mediated K63-linked polyubiquitination targets misfolded DJ-1 to aggresomes via binding to HDAC6. J. Cell Biol. 2007, 178, 1025-1038.
13. Sang, L., Roberts, J. M., Coller, H. A., Hijacking HES1: how tumors co-opt the anti-differentiation strategies of quiescent cells. Trends Mol. Med. 2010, 16, 17-26.
14. Juan, L. J., Shia, W. J., Chen, M. H., Yang, W. M. et al., Histone deacetylases specifically down-regulate p53-dependent gene activation. J. Biol. Chem. 2000, 275, 20436-20443.
15. Meng, L., Li, P., Wang, Y., Wang, C. et al., Gene network study revealed molecular links among genes for alcohol metabolism and breast cancer susceptibility. Bioinformat. Biomed. Eng. 2009, 3, 1-4.
16. Chittur, S. V., Sangster-Guity, N., McCormick, P. J., Histone deacetylase inhibitors: a new mode for inhibition of cholesterol metabolism. BMC Genomics 2008, 9, 507.
17. Stransky, N., Vallot, C., Reyal, F., Bernard-Pierrot, I. et al., Regional copy number-independent deregulation of transcription in cancer. Nat. Genet. 2006, 38, 1386-1396.
18. Cecconi, D., Donadelli, M., Scarpa, A., Milli, A. et al., Proteomic analysis of pancreatic ductal carcinoma cells after combined treatment with gemcitabine and trichostatin A. J. Proteome Res. 2005, 4, 1909-1916.
19. Miyanaga, A., Gemma, A., Noro, R., Kataoka, K. et al., Antitumor activity of histone deacetylase inhibitors in non-small cell lung cancer cells: development of a molecular predictive model. Mol. Cancer Ther. 2008, 7, 1923-1930.
20. Salisbury, C. M., Cravatt, B. F., Activity-based probes for proteomic profiling of histone deacetylase complexes. Proc. Natl. Acad. Sci. USA 2007, 104, 1171-1176.
21. Bantscheff, M., Hopf, C., Savitski, M. M., Dittmann, A. et al., Chemoproteomics profiling of HDAC inhibitors reveals selective targeting of HDAC complexes. Nat. Biotechnol. 2011, 29, 255-265.
22. Hempel, J., von Bahr-Lindstrom, H., Jornvall, H., Aldehyde dehydrogenase from human liver. Primary structure of the cytoplasmic isoenzyme. Eur. J. Biochem. 1984, 141, 21-35.
23. Kursula, P., Sikkila, H., Fukao, T., Kondo, N., Wierenga, R. K., High resolution crystal structures of human cytosolic thiolase (CT): a comparison of the active sites of human CT, bacterial thiolase, and bacterial KAS I. J. Mol. Biol. 2005, 347, 189-201.